Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Contingent Liabilities

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹311 Cr₹159 Cr₹158 Cr₹141 Cr₹146 Cr

What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?

The latest Contingent Liabilities ratio of AUROBINDO PHARMA is ₹311 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹311 Cr
Mar2023₹159 Cr
Mar2022₹158 Cr
Mar2021₹141 Cr
Mar2020₹146 Cr

How is Contingent Liabilities of AUROBINDO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹311 Cr
96.39
Mar2023 ₹159 Cr
0.50
Mar2022 ₹158 Cr
12.01
Mar2021 ₹141 Cr
-3.53
Mar2020 ₹146 Cr -

Compare Contingent Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹63,873.5 Cr -0.9% -8.1% -10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹398,686.0 Cr 0.8% -1.3% 10.6% Stock Analytics
DIVIS LABORATORIES ₹176,075.0 Cr 1.5% 2.3% 47.2% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 0.9% -3.8% Stock Analytics
DR REDDYS LABORATORIES ₹109,971.0 Cr -0.1% 7.2% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,121.0 Cr -2.7% -0.3% 9.9% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.9%

-8.1%

-10.3%

SENSEX

0.1%

1.2%

6%


You may also like the below Video Courses